Bernard Malfroy-camine - Net Worth and Insider Trading

Bernard Malfroy-camine Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Bernard Malfroy-camine owns 1 companies in total, including Kiora Pharmaceuticals Inc (KPRX) .

Click here to see the complete history of Bernard Malfroy-camine’s form 4 insider trades.

Insider Ownership Summary of Bernard Malfroy-camine

Ticker	Comapny	Transaction Date	Type of Owner
KPRX	Kiora Pharmaceuticals Inc	2020-02-14	director

Bernard Malfroy-camine Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Bernard Malfroy-camine Ownership Network

Ownership Network List of Bernard Malfroy-camine

No Data

Ownership Network Relation of Bernard Malfroy-camine

Bernard Malfroy-camine Owned Company Details

What does Kiora Pharmaceuticals Inc do?

Who are the key executives at Kiora Pharmaceuticals Inc?

Bernard Malfroy-camine is the director of Kiora Pharmaceuticals Inc. Other key executives at Kiora Pharmaceuticals Inc include EVP of Finance Melissa Tosca , Chief Development Officer Eric Joseph Daniels , and director & President and CEO Brian M. Strem .

Kiora Pharmaceuticals Inc (KPRX) Insider Trades Summary

Over the past 18 months, Bernard Malfroy-camine made no insider transaction in Kiora Pharmaceuticals Inc (KPRX). Other recent insider transactions involving Kiora Pharmaceuticals Inc (KPRX) include a net purchase of 2,100 shares made by Melissa Tosca , a net purchase of 5,260 shares made by Erin Parsons , and a net purchase of 5,000 shares made by Praveen Tyle .

In summary, during the past 3 months, insiders sold 0 shares of Kiora Pharmaceuticals Inc (KPRX) in total and bought 12,500 shares, with a net purchase of 12,500 shares. During the past 18 months, 0 shares of Kiora Pharmaceuticals Inc (KPRX) were sold and 22,291 shares were bought by its insiders, resulting in a net purchase of 22,291 shares.

Kiora Pharmaceuticals Inc (KPRX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Kiora Pharmaceuticals Inc Insider Transactions

No Available Data

Bernard Malfroy-camine Mailing Address

Above is the net worth, insider trading, and ownership report for Bernard Malfroy-camine. You might contact Bernard Malfroy-camine via mailing address: C/o Burns & Levinson Llp, 125 Summer Street, Boston Ma 02110.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.